Published in J Exp Med on January 01, 1994
The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol (2010) 4.26
Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med (2005) 4.16
Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood (2010) 3.52
Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med (2003) 2.77
The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J (1996) 2.71
A checkpoint for autoreactivity in human IgM+ memory B cell development. J Exp Med (2006) 2.60
Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med (1995) 2.26
The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus. J Clin Invest (2009) 2.11
B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol (2007) 2.08
B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J Exp Med (1998) 2.00
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J Exp Med (2003) 1.89
B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J Exp Med (1996) 1.66
Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med (1997) 1.63
Induction of B-cell immune tolerance by antigen-modified cytotoxic T lymphocytes. Transplantation (2010) 1.43
Signalling crosstalk in B cells: managing worth and need. Nat Rev Immunol (2009) 1.41
Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J Exp Med (1997) 1.41
Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection. J Immunol (2007) 1.35
MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J Exp Med (1999) 1.33
Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc Natl Acad Sci U S A (1997) 1.33
Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B cell population. J Exp Med (1999) 1.31
Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J Exp Med (2002) 1.29
Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival. Proc Natl Acad Sci U S A (2006) 1.25
Activation-induced cytidine deaminase deficiency causes organ-specific autoimmune disease. PLoS One (2008) 1.21
Molecular underpinning of B-cell anergy. Immunol Rev (2010) 1.20
BAFF and the plasticity of peripheral B cell tolerance. Curr Opin Immunol (2008) 1.20
Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell help. J Exp Med (2006) 1.17
Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy. J Exp Med (1997) 1.13
Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model. J Immunol (2008) 1.13
Spontaneous follicular exclusion of SHP1-deficient B cells is conditional on the presence of competitor wild-type B cells. J Exp Med (1998) 1.12
The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity. Ann Rheum Dis (2006) 1.11
Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J Exp Med (1998) 1.09
Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM. J Immunol (2011) 1.08
Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J Exp Med (1995) 1.07
Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b. Immunity (2007) 1.06
B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J Immunol (2004) 1.05
Gene dose-dependent maturation and receptor editing of B cells expressing immunoglobulin (Ig)G1 or IgM/IgG1 tail antigen receptors. J Exp Med (2000) 1.04
Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase. EMBO J (1998) 1.01
Loss of the proapoptotic protein, Bim, breaks B cell anergy. J Exp Med (2006) 1.01
The riddle of the dual expression of IgM and IgD. Immunology (2006) 0.99
Activation and negative selection of functionally distinct subsets of antibody-secreting cells by influenza hemagglutinin as a viral and a neo-self antigen. J Exp Med (1996) 0.99
B-cell antigen-receptor signalling in lymphocyte development. Immunology (2003) 0.99
Modelling cell lifespan and proliferation: is likelihood to die or to divide independent of age? J R Soc Interface (2005) 0.96
B effector cells in rheumatoid arthritis and experimental arthritis. Autoimmunity (2012) 0.95
B cells and aging: balancing the homeostatic equation. Exp Gerontol (2007) 0.93
B cells from knock-in mice expressing broadly neutralizing HIV antibody b12 carry an innocuous B cell receptor responsive to HIV vaccine candidates. J Immunol (2013) 0.91
A B cell receptor with two Igalpha cytoplasmic domains supports development of mature but anergic B cells. J Exp Med (2004) 0.88
Immunological aspects in chronic lymphocytic leukemia (CLL) development. Ann Hematol (2012) 0.88
Clonal anergy of B cells: a flexible, reversible, and quantitative concept. J Exp Med (1996) 0.88
Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG. Proc Natl Acad Sci U S A (1997) 0.86
Liver-expressed Igkappa superantigen induces tolerance of polyclonal B cells by clonal deletion not kappa to lambda receptor editing. J Exp Med (2011) 0.85
Human immunoglobulin (IgG) induced deletion of IgM rheumatoid factor B cells in transgenic mice. J Exp Med (1995) 0.85
The function and regulation of immunoglobulin D. Curr Opin Immunol (2011) 0.84
Rescue of self-reactive B cells by provision of T cell help in vivo. Eur J Immunol (1998) 0.84
Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen. J Immunol (2010) 0.83
Bruton's tyrosine kinase promotes persistence of mature anti-insulin B cells. J Immunol (2014) 0.81
Mechanisms of central tolerance for B cells. Nat Rev Immunol (2017) 0.81
Manipulating B cell homeostasis: a key component in the advancement of targeted strategies. Arch Immunol Ther Exp (Warsz) (2008) 0.80
B cell activating factor (BAFF) and T cells cooperate to breach B cell tolerance in lupus-prone New Zealand Black (NZB) mice. PLoS One (2010) 0.80
B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation. Transplant Rev (Orlando) (2010) 0.79
B-cell extrinsic CR1/CR2 promotes natural antibody production and tolerance induction of anti-alphaGAL-producing B-1 cells. Blood (2006) 0.79
Omalizumab may decrease IgE synthesis by targeting membrane IgE+ human B cells. Clin Transl Allergy (2013) 0.79
B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigens. J Autoimmun (2015) 0.78
Kinetic modeling reveals a common death niche for newly formed and mature B cells. PLoS One (2010) 0.78
Antigen-specific suppression of humoral immunity by anergic Ars/A1 B cells. J Immunol (2012) 0.78
Beyond transitional selection: New roles for BLyS in peripheral tolerance. Drug Dev Res (2011) 0.76
B cell clonal elimination induced by membrane-bound self-antigen may require repeated antigen encounter or cell competition. Eur J Immunol (2000) 0.76
Does B cell receptor signaling in chronic lymphocytic leukaemia cells differ from that in other B cell types? Scientifica (Cairo) (2014) 0.75
Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature (1988) 11.55
Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med (1991) 10.87
Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science (1982) 10.61
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature (1988) 9.17
Germ-line transformation of mice. Annu Rev Genet (1986) 8.67
Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. Immunol Rev (1982) 6.43
Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med (1993) 5.49
Receptor editing in self-reactive bone marrow B cells. J Exp Med (1993) 5.49
Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature (1989) 5.48
Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens. Eur J Immunol (1978) 5.35
B cells turn off virgin but not memory T cells. Science (1992) 4.12
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04
Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02
Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med (1992) 3.52
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med (1993) 2.78
The bulk of the peripheral B-cell pool in mice is stable and not rapidly renewed from the bone marrow. Proc Natl Acad Sci U S A (1990) 2.47
Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol (1992) 2.15
Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science (1991) 1.97
Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell Immunol (1973) 1.94
Flow cytometric analysis of cell proliferation dynamics in the B cell compartment of the mouse. Int Immunol (1989) 1.89
Mapping the antigenic epitope for a monoclonal antibody against lysozyme. J Immunol (1982) 1.87
Breakdown of self-tolerance in anergic B lymphocytes. Nature (1991) 1.87
Peripheral B cell maturation. I. Immature peripheral B cells in adults are heat-stable antigenhi and exhibit unique signaling characteristics. J Immunol (1992) 1.77
Development and follicular localization of tolerant B lymphocytes in lysozyme/anti-lysozyme IgM/IgD transgenic mice. Int Immunol (1992) 1.52
Self tolerance in the B-cell repertoire. Immunol Rev (1991) 1.22
Cellular and molecular mechanisms of B lymphocyte tolerance. Adv Immunol (1992) 1.02
Cellular mechanisms of self-tolerance. Curr Opin Immunol (1989) 0.82
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04
Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02
Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med (1970) 3.40
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors. J Exp Med (1972) 2.48
Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. J Immunol (1985) 2.40
Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science (1991) 1.97
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
Cell interactions in the immune response in vitro. 3. Specific collaboration across a cell impermeable membrane. J Exp Med (1972) 1.96
Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell Immunol (1973) 1.94
Receptor for antibody-antigen complexes used to separate T cells from B cells. Nat New Biol (1972) 1.87
Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography. J Exp Med (1986) 1.78
Homology of the 70-kilodalton antigens from Mycobacterium leprae and Mycobacterium bovis with the Mycobacterium tuberculosis 71-kilodalton antigen and with the conserved heat shock protein 70 of eucaryotes. Infect Immun (1989) 1.75
Mechanisms for eosinophilic and neutrophilic leucocytoses. Br Med J (1971) 1.66
Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants. J Exp Med (1975) 1.58
Specific collaboration between T and B lymphocytes across a cell impermeable membrane in vitro. Nat New Biol (1972) 1.49
Mechanism of eosinophilia. 3. Suppression of eosinophilia by agents known to modify immune responses. Blood (1970) 1.48
Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46
Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival. Blood (2001) 1.45
Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood (2001) 1.37
A subpopulation of T cells bearing Fc receptors. J Immunol (1975) 1.35
Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med (1992) 1.33
Sequence and immunogenicity of the 70-kDa heat shock protein of Mycobacterium leprae. J Immunol (1991) 1.31
Humoral and cell mediated responses in vitro of spleen cells from mice with thymic aplasia (nude mice). Aust J Exp Biol Med Sci (1972) 1.26
The characterization and immunoreactivity of a 70 kD protein common to Mycobacterium leprae and Mycobacterium bovis (BCG). Lepr Rev (1986) 1.24
Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields. Radiat Res (1997) 1.23
Immune function in aged mice. II. B-cell function. Cell Immunol (1977) 1.20
HLA family studies and multiple sclerosis: A common gene, dominantly expressed. Hum Immunol (1981) 1.19
Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells. Int J Cancer (1975) 1.18
Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice. Proc Natl Acad Sci U S A (1990) 1.17
Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids. Infect Immun (1989) 1.16
B cell life span: a review. Immunol Cell Biol (1997) 1.15
Suppressor cells in humoral immunity and tolerance. Br Med Bull (1976) 1.14
Suppressor T cell memory. II. The role of memory suppressor T cells in tolerance to human gamma globulin. J Exp Med (1983) 1.14
Influences on the lifespan of B cell subpopulations defined by different phenotypes. Eur J Immunol (1997) 1.14
Cell interactions in the immune response in vitro. I. Metabolic activities of T cells in a collaborative antibody response. Eur J Immunol (1972) 1.13
Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy. J Exp Med (1997) 1.13
The need for central and peripheral tolerance in the B cell repertoire. Science (1990) 1.12
B cell activation, tolerance and antigen-presenting function. Curr Opin Immunol (1995) 1.12
Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci U S A (1994) 1.11
Immune function in aged mice. I. T-cell responsiveness using phytohaemagglutinin as a functional probe. Cell Immunol (1977) 1.10
Suppressor T-cell memory. Nature (1978) 1.10
Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme. Proc Natl Acad Sci U S A (1991) 1.09
Immune complexes in thrombocytopenic patients: cause or effect? Br J Haematol (1980) 1.09
Immune function in aged mice. IV. Loss of T cell and B cell function in thymus-dependent antibody responses. Eur J Immunol (1978) 1.09
Post-mammoplasty connective tissue disease. Arthritis Rheum (1982) 1.08
Antigens of Mycobacterium leprae identified by immunoprecipitation with sera from leprosy and tuberculosis patients. Clin Exp Immunol (1988) 1.05
Dominant cell wall proteins of Mycobacterium leprae recognized by monoclonal antibodies. Clin Exp Immunol (1987) 1.04
Mechanisms of tolerance to self. Curr Opin Immunol (1996) 1.04
Suppressor T cells in tolerance to non-self and self antigens. Cold Spring Harb Symp Quant Biol (1977) 1.03
Individuals from different populations identify multiple and diverse T-cell determinants on mycobacterial HSP70. Scand J Immunol (1994) 1.03
Loss of immune competence with age may be due to a qualitative abnormality in lymphocyte membranes. Nature (1979) 1.03
T cell reactivity to the purified mycobacterial antigens p65 and p70 in leprosy patients and their household contacts. Clin Exp Immunol (1990) 1.01
Selective cytotoxicity of anti-kappa serum for B lymphocytes. Nat New Biol (1972) 0.98
HLA-DW2, viral immunity and family studies in multiple sclerosis. J Neurol Sci (1977) 0.97
Complementary relationship between repetitive sequences in the SV40 early gene pre-promoter enhancing region and big-T antigen splice junction exons. J Theor Biol (1984) 0.96
Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function. J Clin Lab Immunol (1980) 0.95
Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice. J Exp Med (1998) 0.95
What are killer cells and what do they do? Blood Rev (1988) 0.94
"Sneaking through": a T-cell-dependent phenomenon. Br J Cancer (1981) 0.92
T cell-dependent suppression of antibody production. I. Characteristics of suppressor T cells following tolerance induction. Eur J Immunol (1978) 0.92
The variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein is the target for humoral immune responses. Infect Immun (1992) 0.92
Total lipodystrophy--a report of a case with peripheral neuropathy and glomerulonephritis. Aust N Z J Med (1983) 0.92
A role for suppressor T cells in induction of self-tolerance. Proc Natl Acad Sci U S A (1985) 0.91
Human antigen-specific IgA responses in blood and secondary lymphoid tissue: an analysis of help and suppression. J Immunol (1984) 0.91
Antigens and allergens from the common house dust mite Dermatophagoides pteronyssinus. Part II. Identification of the major IgE-binding antigens by crossed radioimmunoelectrophoresis. J Allergy Clin Immunol (1984) 0.91
Induction of memory and effector suppressor T cells by perinatal exposure to antigen. Eur J Immunol (1984) 0.91
Immune function in aged mice. V. Role of suppressor cells. J Immunol (1980) 0.90
T cell clones from a non-leprosy exposed subject recognize the Mycobacterium leprae 18-kD protein. Clin Exp Immunol (1995) 0.89
Detection of membrane-associated antigens on lymphoid cells by antibody coupled to staphylococcal protein A. J Immunol (1975) 0.88
Use of phenolic glycolipid 1 for serodiagnosis of leprosy in a high prevalence village in Papua New Guinea. Trans R Soc Trop Med Hyg (1987) 0.88
Alpha-interferon (Wellferon) as an adjunct to standard surgical therapy in the management of recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol (1988) 0.88
Immune system of the gastrointestinal tract. Int Rev Physiol (1983) 0.87
Subclinical infection with Mycobacterium leprae--a problem for leprosy control strategies. Trans R Soc Trop Med Hyg (1993) 0.87
Hen egg-white lysozyme-specific T cells elicited in hen egg-white lysozyme-transgenic mice retain an imprint of self-tolerance. J Immunol (1993) 0.86
Identification of biological false positives in anti-HIV antibody tests. AIDS (1987) 0.86
Transfer factor in treatment of multiple sclerosis. Lancet (1980) 0.86
Scleroderma in carcinoma. Med J Aust (1966) 0.86
Isolation and structural characteristics of a monoclonal antibody-defined cross-reactive phospholipid antigen from Mycobacterium tuberculosis and Mycobacterium leprae. J Biol Chem (1991) 0.86
B-cell activation versus tolerance--the central role of immunoglobulin receptor engagement and T-cell help. Int Rev Immunol (1997) 0.85
Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium-specific epitopes rather than shared epitopes. Infect Immun (1997) 0.85
Familial hypersensitivity pneumonitis. Am J Med (1975) 0.84
A receptor for antibody on B lymphocytes. III. Relationship to immunoglobulin and ia determinants. Int Arch Allergy Appl Immunol (1976) 0.84
Whither the anergic B-cell? Autoimmunity (1994) 0.84
Rescue of self-reactive B cells by provision of T cell help in vivo. Eur J Immunol (1998) 0.84
The successful treatment of primary amyloidosis with intermittent chemotherapy. Aust N Z J Med (1978) 0.83
Immunopurification of radiolabelled antigens of Mycobacterium leprae and Mycobacterium bovis (bacillus Calmette-Guerin) with monoclonal antibodies. Scand J Immunol (1987) 0.83
Identification of human T cell epitopes in the Mycobacterium leprae heat shock protein 70-kD antigen. Clin Exp Immunol (1993) 0.83
Characterization of the functional properties of the 70-kDa protein of Mycobacterium bovis. J Biol Chem (1991) 0.83
Current status of interferon therapy. Med J Aust (1984) 0.82
Standardization of antigen E in ragweed pollen extracts using a monoclonal antibody-based enzyme immunoassay. J Allergy Clin Immunol (1983) 0.82
Loss of secretion in mouse-human hybrids need not be due to the loss of a structural gene. J Exp Med (1982) 0.82
Analysis of allergen-specific IgE responses in 341 allergic patients. Associations between allergens and between allergen groups and clinical diagnoses. Aust N Z J Med (1985) 0.81